Gladstone scientists have discovered how tau disrupts the ability of brain cells to form new memories in Alzheimer’s disease.
Chris Carrico talks about Gladstone’s sense of connection and his excitement in studying poorly understood diseases.
At the Gladstone Institutes, inspiring and educating the next generation of scientists is a top priority, for when researchers share their knowledge with young minds, they contribute to a legacy that will help shape the future of scientific innovation.
A daily pill to prevent HIV has reduced infections nationwide, and researchers hope that a long-acting injectable form will help expand protection.
Combining the two most powerful biological tools of the 21st century, scientists at the Gladstone Institutes have manipulated the genome of induced pluripotent stem cells for the first time using a variation of the CRISPR system.
Gladstone scientists have discovered how to make a new type of cell that is in between embryonic stem cells and adult heart cells, and that may hold the key to treating heart disease.
Kevin Mullane joins Stephen Freedman in Gladstone’s office of corporate ventures and translation.
Ten years ago, Shinya Yamanaka revolutionized biological research with his discovery of how to turn ordinary skin cells into stem cells with just four key genes.
Todd McDevitt has rapidly enchanced how Gladstone thinks about bioengineering and stem cell biology.
Gladstone showcased the many benefits that it offers to its community at its annual health and benefits fair.
Infectious disease experts at Gladstone held an informational briefing session to explain what is known about the Zika virus and how it might be combatted as infections rise across the globe.
Key proteins involved in gene expression depend on each other when forming a heart in an embryo. But, if left alone, they start to run amok.
Shomyseh Sanjabi received an Innovative, Developmental, Exploratory Award grant from the California HIV/AIDS Research Program to study how HIV hides in the gut.
In a pair of new studies, Gladstone scientists discovered a specific neural circuit that controls walking, and they found that input to this circuit is disrupted in Parkinson’s disease.
How much you eat can influence your genes and affect how you age. Eric Verdin is researching ways to replicate this epigenetic trick with a drug.
Dominik Haddad describes his international journey to bring his passion for neurological research to Gladstone.
Gladstone scientists report tremendous growth and new developments in WikiPathways, an open-access, open-source repository that has grown from a Gladstone experimental project to a valuable resource for scientists across the globe.
Katherine Pollard shares science on big data and high-performance computing with an audience at Google as part of the Gladstone Open Classroom Talks series.
A cross-disciplinary collaboration seeks to connect the clinic and the laboratory and improve the translation of Alzheimer’s disease research.
AIDS pioneer Michael Hulton is using WWII art reparations to support Gladstone and advance the fight against HIV
Scientists at the Gladstone Institutes have successfully converted human skin cells into fully-functional pancreatic cells.
Oriane Matthys shares how her upbringing influenced her path to biomedical research.
With support from the Wilsey Family, Gladstone is studying a rare genetic condition that could provide clues to curing a whole host of diseases.
New findings about Alzheimer’s disease advance the search for more effective treatments.
Since the AIDS pandemic began over three decades ago, more than 75 million people have been infected with HIV, and 38 million people have died. While antiretroviral drugs have had a huge impact, there is still no vaccine and no cure. Treatment must be given for life.